RDY 📈 Dr. Reddy’s Laboratories - Overview

Dr. Reddy's Laboratories Limited is a multinational pharmaceutical company that operates on a global scale, with a diverse range of products and services that cater to various therapeutic categories. The company's business is segmented into three main areas: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment is involved in the manufacture and marketing of prescription and over-the-counter pharmaceutical products, including generic finished dosages that are equivalent to branded formulations. This segment also has a biologics business, which is a rapidly growing area in the pharmaceutical industry. Additionally, the company's Global Generics segment offers a range of products that are marketed under brand names, providing patients with access to affordable and high-quality medications.

The PSAI segment is focused on the manufacture and marketing of active pharmaceutical ingredients (APIs) and intermediates, which are the principal ingredients used in the production of finished pharmaceutical products. This segment also provides contract research services, allowing customers to outsource their research and development needs. Furthermore, the PSAI segment manufactures and sells APIs and steroids in accordance with specific customer requirements, providing a high degree of customization and flexibility. The company's expertise in API manufacturing has enabled it to establish long-term relationships with its customers, who rely on Dr. Reddy's Laboratories for the supply of high-quality APIs.

The Others segment is involved in the development of therapies in areas such as oncology and inflammation, as well as research and development of differentiated formulations. This segment also provides digital healthcare and information technology-enabled business support services, which are designed to support the company's pharmaceutical business and provide additional revenue streams. Dr. Reddy's Laboratories offers its products in various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. With a strong presence in the global pharmaceutical market, the company has established itself as a reliable and innovative partner for patients, customers, and healthcare providers.

Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. The company has a strong online presence, with its website providing information on its products, services, and business operations. As a publicly traded company, Dr. Reddy's Laboratories is listed on the New York Stock Exchange (NYSE) under the ticker symbol RDY, and its common stock is traded under the ISIN code US2561352038. The company is classified under the GICS Sub Industry: Pharmaceuticals, reflecting its focus on the development, manufacture, and marketing of pharmaceutical products.